Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Novo Nordisk (NVO) has cemented itself as the leader in the booming weight-loss drug market with blockbuster treatments like ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

The Cleveland Clinic found in a September report that individuals with a version of the gene Neurobeachin were more likely to ...

Morgan Stanley downgraded Novo Nordisk to underweight from equal-weight saying it sees slowing growth of its lucrative GLP-1 ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and ...

An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, ...

“Semaglutide hits one receptor. It was the first one that came out,” he said. “Tirzepatide hits two receptors, and studies ...

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs ...